Hillhurst Biopharmaceuticals Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$1.9M
- Investors
-
9
Hillhurst Biopharmaceuticals General Information
Description
Developer of novel liquid therapeutic gases designed to treat patients with sickle cell disease and other serious conditions. The company's platform enables the oral delivery of low-dose carbon monoxide and other therapeutic gases, managing acute pain and supporting organ transplantation, enabling healthcare providers to address challenges of inhaled gas therapies by ensuring accurate dosing, safety, and convenience without the risks of unwanted inhalation or environmental contamination.
Contact Information
Website
www.hillhurstbio.comCorporate Office
- 3030 Bunker Hill Street
- Suite 117C
- San Diego, CA 92109
- United States
Corporate Office
- 3030 Bunker Hill Street
- Suite 117C
- San Diego, CA 92109
- United States
Hillhurst Biopharmaceuticals Timeline
Hillhurst Biopharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Grant | 28-Mar-2025 | $1.9M | Completed | Clinical Trials - General | ||
| 10. Seed Round | 25-Sep-2023 | Completed | Clinical Trials - General | |||
| 9. Grant | 20-Sep-2023 | Completed | Startup | |||
| 8. Accelerator/Incubator | Completed | Startup | ||||
| 7. Grant | 01-Jan-2021 | Completed | Startup | |||
| 6. Grant | 16-May-2020 | Completed | Startup | |||
| 5. Grant | 01-Jan-2020 | Completed | Startup | |||
| 4. Accelerator/Incubator | 06-Nov-2018 | Completed | Startup | |||
| 3. Grant | 01-Jan-2018 | $2.2M | Completed | Startup | ||
| 2. Grant | 01-Jan-2016 | $1.8M | Completed | Startup |
Hillhurst Biopharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
Hillhurst Biopharmaceuticals Comparisons
Industry
Financing
Details
Hillhurst Biopharmaceuticals Competitors (13)
One of Hillhurst Biopharmaceuticals’s 13 competitors is Volastra, a Venture Capital-Backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Volastra | Venture Capital-Backed | New York, NY | ||||
| Ona Therapeutics | Venture Capital-Backed | Barcelona, Spain | ||||
| Gesynta Pharma | Venture Capital-Backed | Stockholm, Sweden | ||||
| Prevail Therapeutics | Formerly VC-backed | New York, NY | ||||
| Cardurion | Venture Capital-Backed | Burlington, MA |
Hillhurst Biopharmaceuticals Patents
Hillhurst Biopharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025155909-A1 | Solution of nitrous oxide for the treatment of disease | Pending | 19-Jan-2024 | ||
| US-20230277583-A1 | Enteral carbon monoxide for the prevention and treatment of ocular diseases | Pending | 04-Mar-2022 |
Hillhurst Biopharmaceuticals Signals
Hillhurst Biopharmaceuticals Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Eye Institute | Government | |||
| Friedman BioVentures | Venture Capital | Minority | ||
| Octane (California) | Accelerator/Incubator | |||
| National Institute of General Medical Sciences | Government | |||
| National Heart, Lung, and Blood Institute | Government |
Hillhurst Biopharmaceuticals FAQs
-
When was Hillhurst Biopharmaceuticals founded?
Hillhurst Biopharmaceuticals was founded in 2012.
-
Where is Hillhurst Biopharmaceuticals headquartered?
Hillhurst Biopharmaceuticals is headquartered in San Diego, CA.
-
What is the size of Hillhurst Biopharmaceuticals?
Hillhurst Biopharmaceuticals has 9 total employees.
-
What industry is Hillhurst Biopharmaceuticals in?
Hillhurst Biopharmaceuticals’s primary industry is Drug Discovery.
-
Is Hillhurst Biopharmaceuticals a private or public company?
Hillhurst Biopharmaceuticals is a Private company.
-
What is Hillhurst Biopharmaceuticals’s current revenue?
The current revenue for Hillhurst Biopharmaceuticals is .
-
How much funding has Hillhurst Biopharmaceuticals raised over time?
Hillhurst Biopharmaceuticals has raised $1.84M.
-
Who are Hillhurst Biopharmaceuticals’s investors?
National Eye Institute, Friedman BioVentures, Octane (California), National Institute of General Medical Sciences, and National Heart, Lung, and Blood Institute are 5 of 9 investors who have invested in Hillhurst Biopharmaceuticals.
-
Who are Hillhurst Biopharmaceuticals’s competitors?
Volastra, Ona Therapeutics, Gesynta Pharma, Prevail Therapeutics, and Cardurion are some of the 13 competitors of Hillhurst Biopharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process